Publication

Estimation of HIV-1 Incidence Using a Testing History-Based Method; Analysis From the Population-Based HIV Impact Assessment Survey Data in 12 African Countries

Downloadable Content

Persistent URL
Last modified
  • 06/25/2025
Type of Material
Authors
    Stephen A Gurley, Emory UniversityPaul W Stupp, United States Centers for Disease Control and PreventionIan E Fellows, United States Centers for Disease Control and PreventionBharat S Parekh, United States Centers for Disease Control and PreventionPeter W Young, United States Centers for Disease Control and PreventionRay W Shiraishi, United States Centers for Disease Control and PreventionPatrick Sullivan, Emory UniversityAndrew C Voetsch, Emory University
Language
  • English
Date
  • 2023-03-01
Publisher
  • LIPPINCOTT WILLIAMS & WILKINS
Publication Version
Copyright Statement
  • © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 92
Issue
  • 3
Start Page
  • 189
End Page
  • 196
Grant/Funding Information
  • Supported by the US President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of cooperative agreements #U2GGH001271 and #U2GGH001226. The findings and conclusions of this document are those of the authors and do not necessarily represent the official position of the funding agencies.
Abstract
  • Background:Estimating HIV incidence is essential to monitoring progress in sub-Saharan African nations toward global epidemic control. One method for incidence estimation is to test nationally representative samples using laboratory-based incidence assays. An alternative method based on reported HIV testing history and the proportion of undiagnosed infections has recently been described.Methods:We applied an HIV incidence estimation method which uses history of testing to nationally representative cross-sectional survey data from 12 sub-Saharan African nations with varying country-specific HIV prevalence. We compared these estimates with those derived from laboratory-based incidence assays. Participants were tested for HIV using the national rapid test algorithm and asked about prior HIV testing, date and result of their most recent test, and date of antiretroviral therapy initiation.Results:The testing history-based method consistently produced results that are comparable and strongly correlated with estimates produced using a laboratory-based HIV incidence assay (ρ = 0.85). The testing history-based method produced incidence estimates that were more precise compared with the biomarker-based method. The testing history-based method identified sex-, age-, and geographic location-specific differences in incidence that were not detected using the biomarker-based method.Conclusions:The testing history-based method estimates are more precise and can produce age-specific and sex-specific incidence estimates that are informative for programmatic decisions. The method also allows for comparisons of the HIV transmission rate and other components of HIV incidence among and within countries. The testing history-based method is a useful tool for estimating and validating HIV incidence from cross-sectional survey data.
Author Notes
  • Andrew C. Voetsch, PhD, Mailstop US 1-2, 1 Corp Sq Blvd, Atlanta, GA 30329 (e-mail: aav6@cdc.gov)
Keywords
Research Categories
  • Health Sciences, Public Health

Tools

Relations

In Collection:

Items